Federal Court of Australia
FEDERAL COURT OF AUSTRALIA
Pfizer Ireland Pharmaceuticals v Samsung Bioepis Au Pty Ltd [2017] FCA 573 File number: NSD 532 of 2017
Judge: NICHOLAS J
Date of judgment: 24 May 2017
Catchwords: PRACTICE AND PROCEDURE – whether extension of time within which to apply for leave to appeal should be granted – where modest delay – where respondent did not assert application for leave to appeal was untenable
Legislation: Federal Court Rules 2011 (Cth) r 35.14
Cases cited: AHC16 v Minister for Immigration and Border Protection [2017] FCA 152 Décor Corporation Pty Ltd v Dart Industries Inc (1991) 33 FCR 397 FAI General Insurance Company Limited v Southern Cross Exploration NL (1988) 165 CLR 268 Gallo v Dawson (1990) 93 ALR 479 Hunter Valley Developments Pty Ltd v Minister for Home Affairs and Environment (1984) 3 FCR 344 Mehmood v Attorney-General of the Commonwealth [2013] FCA 406 Pfizer Ireland Pharmaceuticals v Samsung Bioepis AU Pty Ltd [2017] FCA 285 Skinner v Commonwealth of Australia [2012] FCA 1194
Date of hearing: 24 May 2017
Registry: New South Wales
Division: General Division
National Practice Area: Intellectual Property
Sub-area: Patents and associated Statutes
Category: Catchwords
Number of paragraphs: 13
Counsel for the Applicants: Mr D Shavin QC with Ms CL Cochrane
Solicitor for the Applicants: DLA Piper
Counsel for the Respondent: Mr DK Catterns QC with Mr D Larish
We try to embed the page this law was scraped from. If the site blocks framing, you still get the link and a local excerpt.
Last checked with source on —
Checking whether the official page can be embedded…
Plain-English simplify of this law: a short summary, key points, and both sides of the argument. Generated on first view via Replicate, then cached. Vote on what helps your study.
No study brief is cached for this law yet. Sign up to generate a plain-English brief.
Sign up to generate